Form 8-K - Current report:
SEC Accession No. 0000917520-25-000014
Filing Date
2025-02-25
Accepted
2025-02-25 06:15:18
Documents
15
Period of Report
2025-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20250225.htm   iXBRL 8-K 48652
2 EX-99.1 ex991q42024earnings.htm EX-99.1 299442
  Complete submission text file 0000917520-25-000014.txt   529528

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20250225.xsd EX-101.SCH 2108
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20250225_def.xml EX-101.DEF 14411
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20250225_lab.xml EX-101.LAB 25403
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20250225_pre.xml EX-101.PRE 14986
17 EXTRACTED XBRL INSTANCE DOCUMENT iart-20250225_htm.xml XML 2721
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 25659167
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)